Under the Medicines, Poisons and Therapeutic Goods Regulation 2026, all activities involving Schedule 8 medicines and substances must be recorded in a drug register.
These Standards set out the requirements for electronic drug registers. Any electronic system used as a drug register for Schedule 8 medicines and substances must comply with these Standards.
Guidance information to support the Standards will be published soon.